201 related articles for article (PubMed ID: 34319549)
1. Using an Automated Algorithm to Identify Potential Drug-Induced Liver Injury Cases in a Pharmacovigilance Database.
Pineda Salgado L; Gupta R; Jan M; Turkoglu O; Estilo A; George V; Rahman MI
Adv Ther; 2021 Sep; 38(9):4709-4721. PubMed ID: 34319549
[TBL] [Abstract][Full Text] [Related]
2. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
3. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.
Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D
Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325
[TBL] [Abstract][Full Text] [Related]
4. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
[TBL] [Abstract][Full Text] [Related]
6. Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.
Yeboah-Korang A; Louissaint J; Tsung I; Prabhu S; Fontana RJ
Drug Saf; 2020 Apr; 43(4):371-377. PubMed ID: 31916081
[TBL] [Abstract][Full Text] [Related]
7. Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.
Louissaint J; Kassab I; Yeboah-Korang A; Fontana RJ
Dig Dis Sci; 2022 Aug; 67(8):4243-4249. PubMed ID: 34427818
[TBL] [Abstract][Full Text] [Related]
8. Signal Detection of Potential Hepatotoxic Drugs: Case-Control Study Using Both a Spontaneous Reporting System and Electronic Medical Records.
Akimoto H; Nagashima T; Minagawa K; Hayakawa T; Takahashi Y; Asai S
Biol Pharm Bull; 2021; 44(10):1514-1523. PubMed ID: 34602560
[TBL] [Abstract][Full Text] [Related]
9. Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance.
Tan EH; Ling ZJ; Ang PS; Sung C; Dan YY; Tai BC
Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1480-1488. PubMed ID: 32844466
[TBL] [Abstract][Full Text] [Related]
10. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.
Brinker AD; Lyndly J; Tonning J; Moeny D; Levine JG; Avigan MI
Drug Saf; 2013 Dec; 36(12):1169-78. PubMed ID: 24178291
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases.
Tan EH; Low EXS; Dan YY; Tai BC
Liver Int; 2018 Apr; 38(4):742-753. PubMed ID: 29193566
[TBL] [Abstract][Full Text] [Related]
12. Assessment of drug-induced liver injury in clinical practice.
Lucena MI; García-Cortés M; Cueto R; Lopez-Duran J; Andrade RJ
Fundam Clin Pharmacol; 2008 Apr; 22(2):141-58. PubMed ID: 18353109
[TBL] [Abstract][Full Text] [Related]
13. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
[TBL] [Abstract][Full Text] [Related]
14. Safety data and withdrawal of hepatotoxic drugs.
Babai S; Auclert L; Le-Louët H
Therapie; 2021; 76(6):715-723. PubMed ID: 29609830
[TBL] [Abstract][Full Text] [Related]
15. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury.
Overby CL; Pathak J; Gottesman O; Haerian K; Perotte A; Murphy S; Bruce K; Johnson S; Talwalkar J; Shen Y; Ellis S; Kullo I; Chute C; Friedman C; Bottinger E; Hripcsak G; Weng C
J Am Med Inform Assoc; 2013 Dec; 20(e2):e243-52. PubMed ID: 23837993
[TBL] [Abstract][Full Text] [Related]
16. Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
Minerali E; Foil DH; Zorn KM; Lane TR; Ekins S
Mol Pharm; 2020 Jul; 17(7):2628-2637. PubMed ID: 32422053
[TBL] [Abstract][Full Text] [Related]
17. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
18. Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone.
Ye JH; Ho YF; On AW; Chen WW; Huang YM; Huang WI; Tang YW
Int J Clin Pharm; 2018 Aug; 40(4):911-920. PubMed ID: 30051228
[TBL] [Abstract][Full Text] [Related]
19. Probable drug-induced liver injury associated with aliskiren: case report and review of adverse event reports from pharmacovigilance databases.
Crepin S; Godet B; Carrier P; Villeneuve C; Merle L; Laroche ML
Am J Health Syst Pharm; 2014 Apr; 71(8):643-7. PubMed ID: 24688038
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
